Covid-19 Impact on Lung Cancer Screening Software Market Size to surge at 19.5% CAGR is expected to reach $37.92 Million in 2025

March 2021 | Report Format: Electronic (PDF)

Lung Cancer Screening Software Market Growth & Trends

The global lung cancer screening software market size is estimated to reach USD 37.92 million by 2025 expanding at a CAGR of 19.5% from 2019 to 2025, according to a new report by Grand View Research, Inc. Growing incidence of lung cancer and rise in implementation of lung cancer screening programs across the globe are some of the significant factors driving the market growth. According to Globocan estimates, about 160,068 new cases of lung cancer were reported in South East Asian region in 2018.

A number of clinical trials, studies, and demonstration projects are being conducted around the world to evaluate the effectiveness of lung cancer screening programs. For instance, in 2017, Cancer Care Ontario launched a screening pilot trial for people at high risk. Favorable government initiatives for successful implementation of such programs and increasing awareness about the disease screening are also likely to contribute to the market growth in the coming years.

Lung cancer screening programs are widely adopted by hospitals and radiological centers in U.S. However, they are usually performed as a part of national or provisional screening program outside the country. In case of Latin America and Middle Eastern countries, limited availability of resources, restricted funding, low awareness levels, and lack of trained personnel are some of the factors that impede market growth.

Request a free sample copy or view report summary:
Lung Cancer Screening Software Market Report

Lung Cancer Screening Software Market Report Highlights

  • In 2018, North America accounted for the highest revenue share owing to various lung cancer screening programs and favorable reimbursement scenario in the region
  • Asia Pacific is expected to be the fastest-growing regional market over the forecast period
  • This is attributed to the increasing cases of lung cancer and rise in the number of screening trials & studies for the disease
  • Nuance Communications, Inc.; Eon; Koninklijke Philips N.V.; Siemens Healthineers AG; PenRad Technologies, Inc.; MRS Systems, Inc.; and Magview are some of the key companies in the market

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Create a website or blog at WordPress.com

Up ↑

Create your website with WordPress.com
Get started
%d bloggers like this: